PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Critical Care Department, King Saud Medical City, Riyadh, Kingdom of Saudi Arabia.\', \'Department of Critical Care, Dr Sulaiman Al-Habib Group Hospitals, Riyadh, Saudi Arabia.\', \'Departments of Emergency Medicine and Critical Care Medicine, King Saud University, Riyadh, Saudi Arabia.\', \'Biostatistics Unit, Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.\', \'Division of Gastroenterology & Hepatology, Johns Hopkins University, Baltimore, MD, USA; Liver Transplant Center, and Biostatistics, Epidemiology, and Scientific Computing Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.\', \'Department of Critical Care, Faculty of Medicine and Dentistry, the University of Alberta, Alberta, Canada.\', \'Critical Care Department, King Saud Medical City, Riyadh, Kingdom of Saudi Arabia; Department of Internal Medicine, South Carolina University, School of Medicine, Columbia, SC, USA; Critical Care Department, Keck Medical School, University of Southern California, Los Angeles, CA, USA.\', \'Research & Innovation Centre, King Saud Medical City, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: zmemish@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0924-8579(21)00071-610.1016/j.ijantimicag.2021.106334
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 33838224
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
is ?:relation_isRelatedTo_publication of
?:title
  • Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all